Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ricerca Biosciences, an integrated preclinical CRO providing services to the chemical and biopharmaceutical industries, has received US drug enforcement administration (DEA) license.
Subscribe to our email newsletter
Ricerca offers a spectrum of services for the areas of agrochemical registration, environmental analysis and preclinical discovery and development for biopharmaceutical registration.
Ricerca holds a current DEA license to handle multiple kilos of agency-controlled Schedule II-V substances for research and development projects at its Concord, Ohio, facility. This would include preparation of Phase I to Phase II clinical bulk API supplies.
Rich Donaldson, vice president of chemical development at Ricerca, said: “We have the ability to move forward on clients’ R&D projects that require a DEA license with no delay.